Evaluation of the Effects of Bradykinin Antagonists on Pulmonary Manifestations of COVID-19 Infections (AntagoBrad-Cov Study).
Clinical trial NCT05010876 · COMPLETED
Trial details
- NCT number
- NCT05010876
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2021-06-13
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.